Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs75306531 | chr7:127151869 | A/T | 1.49E-5 | 134 | 42.1 | 37.53 | 100.87 | KM Plot |
| TGCT | rs75352770 | chr6:15244210 | A/G | 6.08E-5 | 133 | 37.95 | 45.1 | NA | KM Plot |
| TGCT | rs75376200 | chr2:29495978 | T/G | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs7539225 | chr1:42113523 | A/G | 0 | 130 | 42.18 | 28.8 | 0.57 | KM Plot |
| TGCT | rs7541822 | chr1:42113693 | T/C | 0 | 131 | 42.1 | 28.8 | 0.57 | KM Plot |
| TGCT | rs75506496 | chr6:15241468 | A/C | 6.08E-5 | 133 | 37.95 | 45.1 | NA | KM Plot |
| TGCT | rs755298 | chr16:27806243 | A/G | 1.34E-5 | 130 | 46.53 | 37.3 | 17.27 | KM Plot |
| TGCT | rs75576474 | chr8:116916019 | TA/T | 8.4E-7 | 133 | 46.3 | 28.7 | 18.83 | KM Plot |
| TGCT | rs7564525 | chr2:3484042 | C/T | 1.99E-5 | 133 | 40.57 | 66.17 | 25.32 | KM Plot |
| TGCT | rs75760574 | chr16:67644173 | G/A | 0 | 133 | 46.07 | 24.1 | 0.57 | KM Plot |
| TGCT | rs75860786 | chr15:34915298 | C/T | 3.26E-5 | 132 | 43.68 | 22.83 | 104.57 | KM Plot |
| TGCT | rs75915514 | chr5:116551905 | C/A | 1.9E-13 | 131 | 46.3 | 28.8 | 17.1 | KM Plot |
| TGCT | rs7593270 | chr2:242136734 | T/C | 0.000159 | 133 | 120.27 | 41.8 | 41.97 | KM Plot |
| TGCT | rs75939744 | chr17:42075144 | G/A | 0 | 128 | 45.83 | 28.7 | 0.57 | KM Plot |
| TGCT | rs7596352 | chr2:3944803 | G/T | 6.98E-11 | 129 | 46.07 | 40.57 | 13.43 | KM Plot |